Prozac: Panacea or puzzle?

Trends in Pharmacological Sciences

Volumn 17, Issue 4, 1996, Pages 150-154

  Stanford, Clare S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CYTOCHROME P450; DESIPRAMINE; DOPAMINE; FLUOXETINE; FLUVOXAMINE; MONOAMINE; NEUROTRANSMITTER RECEPTOR; NORADRENALIN; NORFLUOXETINE; PAROXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

AMINE TRANSPORT; BRAIN REGION; DEPRESSION; DOPAMINE UPTAKE; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HUMAN; MONOAMINE METABOLISM; NONHUMAN; NORADRENALIN UPTAKE; PRIORITY JOURNAL; REVIEW; SEROTONIN UPTAKE; SEROTONINERGIC SYSTEM;

EID: 0342716469     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-6147(96)81591-4     Document Type: Review

References (33)

1. Kramer, P. D. (1993) Listening to Prozac, Viking Penguin
2. Lane, R., Baldwin, D. and Preskorn, S. (1995) J. Pyschopharmacol. 9, 163-178
3. Wong, D. T., Bymaster, F. P., Horng, J. S. and Molloy, B. B. (1975) J. Pharmacol. Exp. Ther. 193, 804-811
4. Fuller, R. W., Perry, K. W. and Molloy, B. B. (1974) Life Sci. 15, 1161-1171
5. Thomas, D. N. and Holman, R. B. (1991) Br. J. Pharmacol. 102, 5P
6. Hughes, Z. A. and Stanford, S. C. (1995) Br. J. Pharmacol. 116, 236P
7. Harms, H. H. (1983) Brain Res. 275, 99-104
8. Bolden-Watson, C. and Richelson, E. (1993) Life Sci. 52, 1023-1029
9. Koe, B. K., Weissman, A., Welch, W. M. and Browne, R. G. (1983) J. Pharmacol. Exp. Ther. 226, 686-700
10. Thomas, D. R., Nelson, D. R. and Johnson, A. M. (1987) Psychopharmacology 93, 193-200
11. Paez, X. and Liebowitz, S. F. (1993) Pharmacol. Biochem. Behav. 46, 933-941
12. Tanda, G., Carboni, E., Frau, R. and Di Chiara, G. (1994) Psychopharmacology 115, 285-288
13. Jordon, S., Kramer, G. L., Zukas, P. K., Moeller, M. and Petty, F. Synapse 18, 294-297
14. Chen, N-H. and Reith, M. E. A. (1994) J. Neurochem. 63, 1701-1713
15. Perry, K. W. and Fuller, R. W. (1992) Life Sci. 50, 1683-1690
16. Matsumoto, M. et al. (1995) J. Pharmacol. Exp. Ther. 272, 1044-1051
17. Mongeau, R., De Montigny, C. and Blier, P. (1994) Eur. J. Pharmacol. 271, 121-129
18. Dailey, J. W., Yan, Q. S., Mishra, P. K., Burger, R. L. and Jobe, P. C. (1992) J. Pharmacol. Exp. Ther. 260, 533-540
19. Beasley, C. M., Masica, D. N. and Povtin, J. H. (1992) Psychopharmacology 107, 1-10
20. Crewe, H. K., Lennard, M. S., Tucker, G. T., Woods, F. R. and Haddock, R. E. (1992) Br. J. Clin. Pharmacol. 34, 262-265
21. Allard, P., Marcusson, J. O. and Ross, S. B. (1994) J. Neurochem. 62, 342-348
22. Nutt, D. J. (1995) J. Psychopharmacol. 9, 205-206
23. Richelson, E. and Pfenning, M. (1984) Eur. J. Pharmacol. 104, 277-286
24. Cheng, C. H. K., Costall, B., Naylor, R. J. and Rudd, J. A. (1993) Eur. J. Pharmacol. 239, 211-214
25. Hyttel, J. and Larsen, J-J. (1985) Acta Pharmacol. Toxicol. 56, 146-153
26. Hyttel, J. (1994) Int. Clin. Psychopharmacol. 9 (Suppl. 1), 19-26
27. Wong, D. T., Horng, J. S., Bymaster, F. P., Hauser, K. L. and Molloy, B. B. (1974) Life Sci. 15, 471-479
28. Richelson, E. and Nelson, A. (1984) J. Pharmacol. Exp. Ther. 230, 94-102
29. Cusack, B., Nelson, A. and Richelson, E. (1994) Psychopharmacology 114, 559-565
30. Jenck, F., Moreau, J-L., Mutel, V., Martin, J. R. and Haefely, W. E. (1993) Eur. J. Pharmacol. 231, 223-229
31. Wood, M. D., Broadhurst, A. M. and Wyllie, M. G. (1986) Neuropharmacology 25, 519-525
32. Sette, M., Briley, M. S. and Langer, S. Z. (1983) J. Neurochem. 40, 622-628
33. Koe, B. K., Lebel, L. A. and Welch, W. M. (1990) Psychopharmacology 100, 470-476